The limitations of the study are as follows: First, the causality between serum apolipoprotein A1 and cognitive impairment in patients with T2DM is unclear due to the cross-sectional design of this study, therefore, the interpretation of the results should be done with caution. The gene discussed is APOA1; the disease is Cognitive impairment.